{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:08:33Z","timestamp":1747040913881,"version":"3.32.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsps.2019.11.023","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T02:29:06Z","timestamp":1575685746000},"page":"210-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-1098","authenticated-orcid":false,"given":"Sirajudeen Shaik","family":"Alavudeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moteb","family":"Khobrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.K.","family":"Dhanapal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javid Iqbal","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan Mohammed","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noohu Abdullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6194-7092","authenticated-orcid":false,"given":"Abdulaziz","family":"Alhossan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jsps.2019.11.023_b0005","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.2337\/dc19-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20132019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jsps.2019.11.023_b0010","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/1753-0407.12575","article-title":"Is insulin the preferred treatment for HbA1c >9%?","volume":"9","author":"Bloomgarden","year":"2017","journal-title":"J. Diabetes"},{"issue":"6","key":"10.1016\/j.jsps.2019.11.023_b0015","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc08-2117","article-title":"DURAbility of basal versus lispro mix 75\/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75\/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes","volume":"32","author":"Buse","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/dc10-1701","article-title":"The DURAbility of Basal versus Lispro mix 75\/25 insulin Efficacy (DURABLE) trial: Comparing the durability of lispro mix 75\/25 and glargine","volume":"34","author":"Buse","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jsps.2019.11.023_b0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1592\/phco.2005.25.6.810","article-title":"Secondary failure rates associated with Metformin and sulphonylurea therapy for T2DM patients","volume":"25","author":"Eurich","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00125-005-0108-0","article-title":"The market in diabetes","volume":"49","author":"Hauber","year":"2006","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0035","article-title":"Insulin monotherapy versus insulin combined with other glucose-lowering agents in Type 2 diabetes: a narrative review","volume":"16","author":"Hengameh","year":"2018","journal-title":"Int. J. EndocrinolMetab."},{"key":"10.1016\/j.jsps.2019.11.023_b0040","unstructured":"Highlights of Prescribing Information, 2011. Novo Log\u00ae Mix 70\/30. Novo Nordisk Inc., Princeton, NJ. September 2011. Available from: http:\/\/www.novo-pi.com\/novologmix7030.pdf (accessed 22 November 2012)."},{"key":"10.1016\/j.jsps.2019.11.023_b0045","first-page":"3190849","article-title":"Insulin adherence in Type 2 diabetes in Mexico: behaviors and barriers","volume":"2018","author":"Janneth","year":"2018","journal-title":"J Diabetes Res."},{"key":"10.1016\/j.jsps.2019.11.023_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153594","article-title":"Association between insulin monotherapy versus insulin plus metformin and the risk of all-cause mortality and other serious outcomes: a retrospective cohort study","volume":"11","author":"Holden","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2310\/6650.2007.06036","article-title":"Insulin as initial therapy in type 2 diabetes: effective, safe, andwell accepted","volume":"55","author":"Lingvay","year":"2007","journal-title":"J Investig Med"},{"issue":"10","key":"10.1016\/j.jsps.2019.11.023_b0060","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc09-0653","article-title":"Insulin-based versus triple oral therapyfor newly diagnosed type 2 diabetes","volume":"32","author":"Lingvay","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jsps.2019.11.023_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b4324","article-title":"Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial","volume":"339","author":"Lund","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jsps.2019.11.023_b0070","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3904\/kjim.2017.354","article-title":"Combination therapy of oral hypoglycemic agents","volume":"32","author":"Moon","year":"2017","journal-title":"Korean J Intern Med"},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00592-015-0790-4","article-title":"Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment","volume":"53","author":"Noale","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jsps.2019.11.023_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res ClinPract"},{"issue":"8","key":"10.1016\/j.jsps.2019.11.023_b0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-149-8-200810210-00242","article-title":"Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes","volume":"149","author":"Qayyum","year":"2008","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jsps.2019.11.023_b0090","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1592\/phco.27.8.1102","article-title":"Loss of glycaemic control in patients with T2DM who were receiving initial metformin, sulphonylurea or TZD monotherapy","volume":"27","author":"Reidel","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.jsps.2019.11.023_b0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3949\/ccjm.70.8.702","article-title":"Is there a role for metformin or acarbose as a weight-loss agent in the absence of diabetes?","volume":"70","author":"Siraj","year":"2003","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"10.1016\/j.jsps.2019.11.023_b0100","first-page":"27","article-title":"Comparison of efficacy and safety of basal and premixed insulin regimens among Type II diabetes patients transiting from oral agents to insulin","volume":"6","author":"Sirajudeen","year":"2013","journal-title":"IJOPP"},{"issue":"4","key":"10.1016\/j.jsps.2019.11.023_b0105","first-page":"416","article-title":"Benefits and pitfalls of using insulin in the management of type 2 diabetes patients: a clinical evaluation","volume":"6","author":"Sirajudeen","year":"2014","journal-title":"J. App. Pharm."},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0110","first-page":"13","article-title":"Comparison of the glycemic control of insulin and triple oral therapy in type 2 diabetes mellitus","volume":"1","author":"Tri Murti","year":"2010","journal-title":"J. Diabetes Endocrinol."},{"issue":"22","key":"10.1016\/j.jsps.2019.11.023_b0115","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1001\/jama.2014.5951","article-title":"Insulin therapy for type 2 diabetes mellitus","volume":"311","author":"Wallia","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jsps.2019.11.023_b0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.25.2.330","article-title":"Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)","volume":"25","author":"Wright","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jsps.2019.11.023_b0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/dia.2011.0168","article-title":"The impact of initiating biphasic human insulin 30 therapy in Type 2 diabetes patients after failure of oral antidiabetes drugs","volume":"14","author":"Yunjuan","year":"2012","journal-title":"Diabetes Technol Ther."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016419301719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016419301719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:24:07Z","timestamp":1736184247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016419301719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1319016419301719"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2019.11.023","relation":{},"ISSN":["1319-0164"],"issn-type":[{"type":"print","value":"1319-0164"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2019.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}